Insurance

Airrosti launches REACH, a new platform combining its proven myofascial release model with digital tools to tackle the $350B MSK problem.

During Super Bowl week, Health Net and NFL Hall of Famers honored heroes and inspired youth, a strategic move in California's tough healthcare market.

Named MGA of the Year, Resilience’s data-driven model merging tech and insurance is disrupting the European market and setting a new standard for risk.

RegEd's landmark achievement in data processing highlights a critical shift in financial services, where automated RegTech is no longer a luxury but a necessity.

Fluent sells its Winopoly subsidiary to focus on its booming Commerce Media business, a strategic pivot aiming for long-term value amid a shifting AdTech landscape.

EMD Serono and the Trump Administration launch a new program offering massive discounts on IVF drugs, bringing hope to millions of aspiring parents.

Denver-based AAI secures major private equity backing to scale its tech-driven platform, promising rapid expansion and enhanced support for independent agents.

With only 20% of Aussie SMEs insured against cyber threats, Cowbell and Zurich launch an AI-powered platform to simplify and expand coverage.

With its Q4 results announcement imminent, specialty insurer Trisura is under scrutiny to prove it can sustain growth amid market pressures and investor concerns.

New federal legislation aims to unify Canada's fragmented health records, but can it overcome deep-rooted privacy fears and technical hurdles?

Sun Life and DentaQuest open nominations for their Health Access Hero Awards, offering grants to groups fighting critical health disparities.

With nearly three decades of experience, new president Dan Huynn is tasked with transforming Genstone Insurance into a national powerhouse. Here's his plan.

A new study reveals why Sickle Cell Disease patients suffer from frequent crises and rely on pain pills, even with awareness of multi-million dollar cures.

A major multifamily operator expands its use of AI surveillance as soaring insurance costs and liability lawsuits force a shift to proactive, tech-driven security.

Despite product withdrawals, a lack of regulation and the long latency of asbestos-related diseases mean the danger from talc exposure is far from over.

A new report reveals how GLP-1 drugs are accelerating a major healthcare shift in the Gulf, turning metabolic health into a core economic and policy issue.

Positive study results for Alvotech's Entyvio biosimilar could disrupt the IBD market, promising lower costs for a blockbuster chronic care treatment.

The insurance giant beat adjusted earnings estimates on strong operational performance, even as derivative losses weighed on its reported GAAP revenue.

The first new F1 team in a decade, Cadillac is embedding TWG AI from day one, betting on an intelligence-native approach to challenge the grid in 2026.

AIROS Medical's FDA-cleared ARTAIRA device brings non-invasive PAD therapy home as global cases are projected to surge past 360 million by 2050.